Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PBMD

Immutep Limited (PBMD)

Immutep Limited
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBMD
DateTimeSourceHeadlineSymbolCompany
02/23/20186:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
02/09/20188:00AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
02/02/20189:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
01/23/20186:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
12/26/201710:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
12/21/20176:55AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
12/13/20176:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
12/05/20176:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
12/01/20176:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/27/20177:12PMGlobeNewswire Inc.Prima BioMed Becomes ImmutepNASDAQ:PBMDImmutep Limited
11/24/201710:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/22/20176:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/21/20176:07PMGlobeNewswire Inc.Prima Secures European Patent Grant for Lead Product IMP321 in CancerNASDAQ:PBMDImmutep Limited
11/21/20176:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/20/201710:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/20/201710:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/20/20171:59AMGlobeNewswire Inc.Prima BioMed Changes Its Name to Immutep LtdNASDAQ:PBMDImmutep Limited
11/16/20176:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/15/20173:11AMGlobeNewswire Inc.Eftilagimod Alpha (LAG-3Ig Or IMP321) Pre-IND Meeting With the FDANASDAQ:PBMDImmutep Limited
11/09/20175:29PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
11/08/20175:45PMGlobeNewswire Inc.New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual...NASDAQ:PBMDImmutep Limited
11/03/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PBMDImmutep Limited
11/01/20177:28AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
10/31/20177:15PMGlobeNewswire Inc.Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017NASDAQ:PBMDImmutep Limited
10/20/20175:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
10/20/20174:58PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
10/19/201711:23PMGlobeNewswire Inc.Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017NASDAQ:PBMDImmutep Limited
10/19/20174:41PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PBMDImmutep Limited
10/19/20174:39PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PBMDImmutep Limited
10/18/20176:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PBMDImmutep Limited
 Showing the most relevant articles for your search:NASDAQ:PBMD